Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 8
1993 8
1994 7
1995 7
1996 11
1997 8
1998 8
1999 4
2000 7
2001 6
2002 1
2003 3
2004 2
2005 3
2006 1
2007 1
2008 5
2009 4
2010 5
2011 5
2012 3
2013 5
2014 3
2015 2
2016 2
2017 2
2018 5
2019 2
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and classification of ulcerative colitis.
Conrad K, Roggenbuck D, Laass MW. Conrad K, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):463-6. doi: 10.1016/j.autrev.2014.01.028. Epub 2014 Jan 11. Autoimmun Rev. 2014. PMID: 24424198 Review.
Dependent on the anatomic extent of involvement, UC can be classified as proctitis, left-sided colitis, or pancolitis. Inflammatory arthropathies and primary sclerosing cholangitis (PSC) are the most common and clinically most important extraintestinal manife …
Dependent on the anatomic extent of involvement, UC can be classified as proctitis, left-sided colitis, or pancolitis. Inflammatory arthropa …
Serology in autoimmune hepatitis: A clinical-practice approach.
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Terziroli Beretta-Piccoli B, et al. Eur J Intern Med. 2018 Feb;48:35-43. doi: 10.1016/j.ejim.2017.10.006. Epub 2017 Oct 19. Eur J Intern Med. 2018. PMID: 29056396 Review.
Type 2 AIH, which is rare and affects mostly children/adolescents, is characterized by anti-liver kidney microsomal 1 and/or anti-liver cytosol 1 antibodies. The presence of anti-neutrophil cytoplasmic antibody (ANCA), particularly atypical p-ANCA
Type 2 AIH, which is rare and affects mostly children/adolescents, is characterized by anti-liver kidney microsomal 1 and/or anti-liver cyto …
The significance of ANCA positivity in patients with inflammatory bowel disease.
Lee WI, Subramaniam K, Hawkins CA, Randall KL. Lee WI, et al. Pathology. 2019 Oct;51(6):634-639. doi: 10.1016/j.pathol.2019.07.002. Epub 2019 Aug 26. Pathology. 2019. PMID: 31466865
Traditionally anti-neutrophil cytoplasmic antibodies (ANCA) are used to subtype patients with inflammatory bowel disease (IBD) and to predict primary sclerosing cholangitis (PSC). ...Sixty-four IBD patients attending our hospital gastroen …
Traditionally anti-neutrophil cytoplasmic antibodies (ANCA) are used to subtype patients with inflammatory bowel diseas …
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH. Hov JR, et al. Liver Int. 2017 Mar;37(3):458-465. doi: 10.1111/liv.13238. Epub 2016 Sep 13. Liver Int. 2017. PMID: 27558072
BACKGROUND & AIMS: The strongest genetic risk factors in primary sclerosing cholangitis (PSC) are encoded in the HLA complex. Antineutrophil cytoplasmic antibodies (ANCA) have been reported in up to 94% of PSC patients, but the …
BACKGROUND & AIMS: The strongest genetic risk factors in primary sclerosing cholangitis (PSC) are encoded in the HL …
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Wunsch E, Norman GL, Milkiewicz M, Krawczyk M, Bentow C, Shums Z, Mahler M, Lopens S, Reinhold D, Franke A, Schramm C, Roggenbuck D, Milkiewicz P. Wunsch E, et al. Aliment Pharmacol Ther. 2021 Jan;53(2):302-313. doi: 10.1111/apt.16153. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159471
BACKGROUND: Primary sclerosing cholangitis (PSC) is associated with progressive liver disease and cholangiocarcinoma. ...CONCLUSIONS: Anti-GP2 and PR3-ANCA are prognostic antibodies in PSC as they identify patients at risk of severe disease, poo …
BACKGROUND: Primary sclerosing cholangitis (PSC) is associated with progressive liver disease and cholangiocarcinoma. . …
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, Kaplan GG, Lindkvist B, Hirschfield GM, Milkiewicz P, Cheung A, Janssen HL, Fritzler MJ. Stinton LM, et al. PLoS One. 2014 Nov 14;9(11):e112877. doi: 10.1371/journal.pone.0112877. eCollection 2014. PLoS One. 2014. PMID: 25397578 Free PMC article.
BACKGROUND AND AIMS: The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil cytoplasmic antibodies (aANCA), which, in addition to having low sensitivity and specificity, is an indirect immunofluorescen …
BACKGROUND AND AIMS: The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil …
The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia.
Lopens S, Krawczyk M, Papp M, Milkiewicz P, Schierack P, Liu Y, Wunsch E, Conrad K, Roggenbuck D. Lopens S, et al. Auto Immun Highlights. 2020 Mar 16;11(1):6. doi: 10.1186/s13317-020-00129-x. Auto Immun Highlights. 2020. PMID: 32178720 Free PMC article. Review.
Unlike in other autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis, the role and nature of autoantigenic targets in primary sclerosing cholangitis (PSC), a progressive, chronic, immune-mediated, life threateni …
Unlike in other autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis, the role and nature of …
Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F, Slametschka D, Gregor M, Weber P. Seibold F, et al. Gastroenterology. 1994 Aug;107(2):532-6. doi: 10.1016/0016-5085(94)90181-3. Gastroenterology. 1994. PMID: 8039629
BACKGROUND/AIMS: Perinuclear antineutrophil cytoplasmic antibodies (pANCA) were found at high frequency in patients with primary sclerosing cholangitis and ulcerative colitis. ...CONCLUSIONS: These data show that pANCA may be a genetic ma …
BACKGROUND/AIMS: Perinuclear antineutrophil cytoplasmic antibodies (pANCA) were found at high frequency in patients wit …
IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C, Terjung B, Lilienweiss P, Beuers U, Herzog V, Sauerbruch T, Spengler U. Schwarze C, et al. Clin Exp Immunol. 2003 Aug;133(2):283-9. doi: 10.1046/j.1365-2249.2003.02195.x. Clin Exp Immunol. 2003. PMID: 12869036 Free PMC article.
Antineutrophil cytoplasmic antibodies (ANCA) of IgG class have been described at high prevalence in autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). ...In sera containing IgG and IgA class ANCA simultaneo
Antineutrophil cytoplasmic antibodies (ANCA) of IgG class have been described at high prevalence in autoimmune h
Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
Dobric S, Popovic D, Nikolic M, Andrejevic S, Spuran M, Bonaci-Nikolic B. Dobric S, et al. Clin Chem Lab Med. 2011 Nov 23;50(3):503-9. doi: 10.1515/CCLM.2011.797. Clin Chem Lab Med. 2011. PMID: 22107137
METHODS: Data from 52 ulcerative colitis (UC) patients with 32 Crohn's disease (CD) patients were compared. Primary sclerosing cholangitis (PSC) was present in 12/84 patients. ANCA, ANA and anti-smooth muscle antibodies (ASMA) were detected by I …
METHODS: Data from 52 ulcerative colitis (UC) patients with 32 Crohn's disease (CD) patients were compared. Primary sclerosing
122 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page